Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapyVanesa Gregorietti, Andrés J. Daniele, Elías Ortega Chahla et al.|Cardio-Oncology|2020Cited by 59
Use of EMPAgliflozin in the prevention of CARDiotoxicity: the EMPACARD – PILOT trialAndrés J. Daniele, Teresa López‐Fernández, Diego Costa et al.|Cardio-Oncology|2024Cited by 32
Anti HER-2 therapies and left ventricular dysfunction: A prospective studyAndrés J. Daniele, Vanesa Gregorietti|Annals of Oncology|2019Cited by 0
Anti-HER-2 therapies and left ventricular dysfunction the renaissance studyAndrés J. Daniele, M.V. Cáceres, S. Daniele et al.|Annals of Oncology|2019Cited by 0